Body mass index matters: morbid obese patients have different microorganism profiles in the setting of periprosthetic hip joint infections.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Declarations. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by an ethical committee (EK number blinded for submission). Consent to participate: Informed consent was obtained from all individual participants included in the study. Consent to publish: A statement confirming that consent to publish has been received from all participants. Competing interests: The authors declare no competing interests. 4. Infect Dis Clin North Am. 2017 Jun;31(2):237-252. doi: 10.1016/j.idc.2017.01.009. Epub 2017 Mar 30. Management of Prosthetic Joint Infection. Tande AJ(1), Gomez-Urena EO(2), Berbari EF(2), Osmon DR(2). Author information: (1)Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address: tande.aaron@mayo.edu. (2)Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. Although uncommon, prosthetic joint infection is a devastating complication. This challenging condition requires a coordinated management approach to achieve good patient outcomes. This review details the general principles to consider when managing patients with prosthetic joint infection. The different medical/surgical treatment strategies and how to appropriately select a strategy are discussed. The data to support each strategy are presented, along with discussion of antimicrobial strategies in specific situations. Copyright © 2017 Elsevier Inc. All rights reserved. DOI: 10.1016/j.idc.2017.01.009